In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...

GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.